CN Patent

CN102918039B — 甲基纳曲酮的口服制剂和亲脂盐

Assigned to Wyeth LLC · Expires 2017-06-09 · 9y expired

What this patent protects

本发明提供了包含甲基纳曲酮或其盐的组合物，及其用于口服施用的组合物和制剂。

USPTO Abstract

本发明提供了包含甲基纳曲酮或其盐的组合物，及其用于口服施用的组合物和制剂。

Drugs covered by this patent

methylnaltrexone-bromide (METHYLNALTREXONE BROMIDE)

Patent Metadata

Patent number: CN102918039B
Jurisdiction: CN
Classification: —
Expires: 2017-06-09
Drug substance claim: No
Drug product claim: No
Assignee: Wyeth LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.